#trial
Latest news and interesting information about trial.
Baku to host US 2nd Global AI Week
Baku will host the US 2nd Global Artificial Intelligence Week. The first Azerbaijan-US Economic Dialogue discussed digital infrastructure, AI, and investment opportunities.
48-hour review for minor crimes
Obvious minor crimes may be reviewed within 48 hours under proposed changes to the Criminal Procedure Code.
Azerbaijani Startups Shine at Silicon Valley Summit
Azerbaijani startups presented at Silicon Valley May Summit 2026's Global Startup Showcase, attracting international investors.
Man jailed for 6 months for assaulting girlfriend in Baku
A man in Baku received a 6-month jail sentence for assaulting his girlfriend. The Nizami District Court convicted Vali Babayev of intentional light bodily harm.
NASA chief: No evidence of aliens
NASA Administrator Jared Isaacman says there is no evidence of aliens or UFOs, supporting transparency efforts.
Cellectar Plans Phase 3 Trial for WM After BTKi
Cellectar Biosciences reports promising Phase 2 results for iopofosine I 131 in Waldenström macroglobulinemia after BTKi therapy, plans Phase 3 trial.
Cogent Stock Price Target Raised to $55
Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.
H.C. Wainwright Reaffirms Mineralys Buy
H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.
ERock Targets $5B Valuation in US IPO
ERock targets up to $5 billion valuation in its US IPO. The natural gas generator maker plans to raise $641.9 million.
US bank CEOs constructive on loan demand
Bank of America analysts report US bank CEOs constructive on loan demand, with stable deposit trends and solid consumer credit quality.
14 Stab Kills Relative Over Home Renovation
Vugar Abuzarov sentenced to 17 years for stabbing his relative 14 times during an argument over home renovation in Saray village.
Vahid Alakbarov's son tops richest heirs list
Yusif Alakbarov, son of LUKOIL co-founder Vahid Alakbarov, tops Forbes' list of richest heirs of Russian billionaires with a $560 million fortune.
India GDP growth slows to 7.2% in Q1
India's GDP growth slowed to 7.2% in Q1 2026, missing forecasts, as external demand weakened.
Lucid Group Names Silvio Napoli CEO
Lucid Group appoints Silvio Napoli as CEO effective immediately. Stock up 12% in past week but down 38% YTD. Company faces financial challenges.
Invinity sells 2 MWh battery for Wisconsin
Invinity Energy Systems sells a 2 MWh vanadium flow battery for a DOE-funded project in Wisconsin.
Man Sent Son to Surgery, Assaulted Daughter-in-Law
Father-in-law sentenced to 4 years for attempting to assault daughter-in-law while son was in surgery. Incident in Zangilan district.
Man who killed wife with cruelty gets 18 years
Hasrat Aliyev sentenced to 18 years for killing his wife with extreme cruelty in Sheki. Details of the trial.
Goldman Sachs Initiates Octave at Neutral
Goldman Sachs initiates Octave Intelligence with Neutral rating and $17 target. Learn about the company's transition and growth drivers.
Genentech to Present Obesity Drug Trial Data at ADA
Genentech presents Phase II data for obesity drugs enicepatide and petrelintide at ADA conference. Latest updates on weight loss treatments.
Could GLP-1 drugs be oncology's next big opportunity?
New research suggests GLP-1 drugs may play a role in cancer prevention and treatment, opening a potential new frontier for these popular therapies.
Rupee under pressure, RBI unlikely to rush into rate hikes
Rupee under pressure but RBI unlikely to rush rate hikes. BofA expects hawkish hold in June with rates unchanged.
Algerian President Ratifies Energy Memo with Azerbaijan
Algerian President Tebboune ratifies energy MoU with Azerbaijan covering oil, gas, petrochemicals, and green energy. SOCAR to supply crude oil.
Warehouse Explosion in Myanmar: 20 Dead
Warehouse explosion in northern Myanmar kills 20, injures dozens. Cause unknown, area under Ta'ang National Liberation Army control.
Revolution Medicines Phase 3 Trial Results
Revolution Medicines announces positive Phase 3 trial results for daraxonrasib in pancreatic cancer, showing significant survival benefit.
Prostate cancer death risk cut by 20% with J&J drug
Johnson & Johnson's apalutamide reduces prostate cancer death risk by 20%, according to Phase 3 trial results.
Saudi Arabia stocks rise at close
Saudi Arabia's Tadawul All Share index rose 0.46% driven by hotels, tourism, and insurance sectors. Top gainers included Saudi Industrial Development Co. and Kingdom Holding.
Brenetafusp Shows Promise in Melanoma
Immunocore's brenetafusp showed 14.3-month median overall survival in Phase 1/2 melanoma trial, supporting Phase 3 development.
J&J prostate cancer drug reduces spread and death risk
J&J's Erleada prostate cancer drug reduces risk of spread and death in late-stage study. New data presented at ASCO.
Novartis radiopharma drug shows promise
Novartis experimental actinium-based radiopharma drug shows anti-tumor activity in prostate cancer, including in patients previously treated with Pluvicto.
Novartis prostate cancer drug shows promise
Novartis experimental actinium-based drug shows promising anti-tumor activity in prostate cancer, significantly reducing PSA levels.
...